COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants.
Junker D, Dulovic A, Becker M, Wagner TR, Kaiser PD, Traenkle B, Kienzle K, Bunk S, Struemper C, Haeberle H, Schmauder K, Ruetalo N, Malek N, Althaus K, Koeppen M, Rothbauer U, Walz JS, Schindler M, Bitzer M, Göpel S, Schneiderhan-Marra N.
Junker D, et al. Among authors: traenkle b.
Sci Rep. 2022 May 3;12(1):7168. doi: 10.1038/s41598-022-10987-2.
Sci Rep. 2022.
PMID: 35505068
Free PMC article.